NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function*

p53 plays a critical role in a variety of growth inhibitory responses, including cell cycle arrest, differentiation, and apoptosis, and contributes to tumor suppression. Here we show that NM23-H1 and its binding partner STRAP (serine-threonine kinase receptor-associated protein) interact with p53 and potentiate p53 activity. Both NM23-H1 and STRAP directly interact with the central DNA binding domain within residues 113-290. The use of NM23-H1 and STRAP mutants revealed that Cys145 of NM23-H1 and Cys152 (or Cys270) of STRAP were responsible for p53 binding. Furthermore, Cys176 and Cys135 of p53 were required to bind NM23-H1 and STRAP, respectively. Ectopic expression of wild-type NM23-H1 and STRAP, but not NM23-H1(C145S) and STRAP(C152S/C270S), positively regulated p53-mediated transcription in a dose-dependent manner. Knockdown of endogenous NM23-H1 or STRAP produced an opposite trend and inhibited the p53-mediated transcription. Similarly, NM23-H1 and STRAP stimulated p53-induced apoptosis and growth inhibition, whereas the NM23-H1(C145S) and STRAP(C152S/C270S) mutants had no effect. We also demonstrated that p53 activation by NM23-H1 and STRAP was mediated by removing Mdm2, a negative regulator of p53, from the p53-Mdm2 complex. These results suggest that NM23-H1 and its interacting partner STRAP physically interact with p53 and positively regulate its functions, including p53-induced apoptosis and cell cycle arrest.

[1]  M. Oren,et al.  Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation , 2001, The EMBO journal.

[2]  F. Zindy,et al.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Fukuda,et al.  Molecular Evolution of Nucleoside Diphosphate Kinase Genes: Conserved Core Structures and Multiple-Layered Regulatory Regions , 2003, Journal of bioenergetics and biomembranes.

[4]  E. Dennis,et al.  Handbook of cell signaling , 2004 .

[5]  Han-Woong Lee,et al.  Jab1 Induces the Cytoplasmic Localization and Degradation of p53 in Coordination with Hdm2* , 2006, Journal of Biological Chemistry.

[6]  N. Pavletich,et al.  Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2 , 1996, Science.

[7]  Adriana L. Gonzalez,et al.  Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. , 2006, Cancer research.

[8]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[9]  B. Stillman,et al.  Analysis of a protein-binding domain of p53 , 1993, Molecular and cellular biology.

[10]  D. Friedman,et al.  Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism. , 2006, Cancer research.

[11]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[12]  P. Steeg,et al.  Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.

[13]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[14]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[15]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[16]  S. Fields,et al.  Two cellular proteins that bind to wild-type but not mutant p53. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Murphy,et al.  The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation , 2001, Molecular and Cellular Biology.

[18]  Kyong-Tai Kim,et al.  3-Phosphoinositide-dependent PDK1 Negatively Regulates Transforming Growth Factor-β-induced Signaling in a Kinase-dependent Manner through Physical Interaction with Smad Proteins* , 2007, Journal of Biological Chemistry.

[19]  Kyong-Tai Kim,et al.  Regulation of Transforming Growth Factor-β Signaling and PDK1 Kinase Activity by Physical Interaction between PDK1 and Serine-Threonine Kinase Receptor-associated Protein* , 2005, Journal of Biological Chemistry.

[20]  K. Vousden,et al.  Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.

[21]  J. Minna,et al.  Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins , 1992, Journal of virology.

[22]  C. Harris,et al.  p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.

[23]  P. Tegtmeyer,et al.  Role of cysteine residues in regulation of p53 function , 1995, Molecular and cellular biology.

[24]  Hyun-A Seong,et al.  NM23-H1 Tumor Suppressor Physically Interacts with Serine-Threonine Kinase Receptor-associated Protein, a Transforming Growth Factor-β (TGF-β) Receptor-interacting Protein, and Negatively Regulates TGF-β Signaling* , 2007, Journal of Biological Chemistry.

[25]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[26]  A. Otero.  NM23/Nucleoside Diphosphate Kinase and Signal Transduction , 2000, Journal of bioenergetics and biomembranes.

[27]  J. Jenkins,et al.  Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen , 1988, Journal of virology.

[28]  Kyong-Tai Kim,et al.  Regulation of Macrophage Migration Inhibitory Factor and Thiol-specific Antioxidant Protein PAG by Direct Interaction* , 2001, The Journal of Biological Chemistry.

[29]  J. Lotem,et al.  NQO1 stabilizes p53 through a distinct pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Latonen,et al.  Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. , 2002, Nucleic acids research.

[31]  Kyusam Choi,et al.  Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. , 2005, Cancer research.

[32]  I. D'Agnano,et al.  nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  R. Honda,et al.  Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 , 1999, The EMBO journal.

[34]  Muyang Li,et al.  Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.

[35]  Xin Lu,et al.  RB regulates the stability and the apoptotic function of p53 via MDM2. , 1999, Molecular cell.

[36]  Thierry Soussi,et al.  Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation , 1996, Nucleic Acids Res..

[37]  M. Pincus,et al.  Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress , 2001, Molecular and Cellular Biology.

[38]  D. George,et al.  Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein* , 1999, The Journal of Biological Chemistry.

[39]  S. Dupont,et al.  Links between Tumor Suppressors p53 Is Required for TGF-β Gene Responses by Cooperating with Smads , 2003, Cell.

[40]  K. Kinzler,et al.  Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.

[41]  T. Caspari.  Checkpoints: How to activate p53 , 2000, Current Biology.

[42]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[43]  H. Matsuo,et al.  Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions , 2006, Molecular and Cellular Biology.

[44]  R. Iggo,et al.  Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells* , 2004, Journal of Biological Chemistry.

[45]  P. May,et al.  Twenty years of p53 research: structural and functional aspects of the p53 protein , 1999, Oncogene.

[46]  M. Fukuda,et al.  Regulation of Cellular Functions by Nucleoside Diphosphate Kinases in Mammals , 2000, Journal of bioenergetics and biomembranes.

[47]  Lai See Po,et al.  The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. , 2002, Cancer research.